Clinical Trial Update: HAL-MPE1 First-in-human [Phase 1]

View source ↗

Summary

HAL Allergy reports the first-in-human Phase 1 trial of HAL-MPE1 for peanut allergy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• HAL-MPE1

Snippet

Sponsor: HAL Allergy | Conditions: Peanut Allergy | Phase 1 | Status: COMPLETED